Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304148 · ClinicalTrials.gov registry record
SDCC - Prospective Cohort Study of Chronic Renal Insufficiency
A clinical trial of Renal Insufficiency, Chronic, sponsored by University of Pennsylvania.
- Active
- Registry status
- 5,499
- Enrollment target
- 12
- Study locations
NCT00304148 is a study of Renal Insufficiency, Chronic that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 5,499 participants, above the 257-participant average among 14 other Renal Insufficiency, Chronic trials with a reported enrollment target (2040% higher). The trial reports 12 study locations across 7 states.
The verdict
NCT00304148, a study of Renal Insufficiency, Chronic, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- 5,499 participants
- Enrollment target
- 12
- Study locations
Study Summary
Chronic kidney disease (CKD) is a silent epidemic affecting more than 37 million Americans. The burden of morbidity and mortality associated with CKD derives from its frequent progression to end-stage kidney disease (ESKD) and the disproportionate risk of cardiovascular disease (CVD) and associated complications. CKD is strongly and independently associated with CVD, even after adjustment for traditional CVD risk factors. This led to the hypothesis that other risk factors augment the rate of CVD in the setting of CKD. Hence, many patients with progressive renal disease succumb to fatal CVD events before they need renal replacement therapy. The National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) established the Chronic Renal Insufficiency Cohort (CRIC) Study in 2001 with the initial goal of elucidating the relationship between CKD and CVD. Since its inception, the CRIC Study has recruited and followed a racially and ethnically diverse cohort of over 5,000 participants with reduced kidney function from 13 clinical recruitment sites across the US. The original aim of CRIC was to establish a clinical research laboratory designed to (a) identify novel predictors of CKD progression, and (b) characterize the manifestations of CVD and identify its risk factors among individuals with CKD. The CRIC Study has examined a broad set of etiological factors (clinical, behavioral, and biomarker-associated) potentially responsible for both progressive CKD and CKD-related morbidities, especially those early in the course of CKD. Characterizing relationships between these risk factors and outcomes should facilitate identification of high-risk subgroups with CKD and guide enrollment into preventive treatment trials and application of preventive therapies. Over time, the scientific focus and the CRIC investigator network have broadened extensively through a highly successful ancillary studies program that has included more than 100 projects, most of which have been fu
Conditions Studied
Study Locations (12)
Ohio
- University Hospitals of Cleveland - Cleveland
- Metrohealth Medical Center - Cleveland
- Cleveland Clinic Foundation - Cleveland
California
- Kaiser Permanente of Northern California - Oakland
- University of California - San Francisco
Maryland
- University of Maryland Medical System - Baltimore
- Johns Hopkins Medical Institutions - Baltimore
Michigan
- University of Michigan Hospitals - Ann Arbor
- Wayne State - Harper University Hospital - Detroit
Illinois
- University of Illinois at Chicago - Chicago
Louisiana
- Tulane University Health Sciences Center - New Orleans
Pennsylvania
- University of Pennsylvania Medical Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,499 participants |
| Start Date | 2003-07 |
| Est. Completion | 2028-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00304148
The ClinicalTrials.gov registry entry for NCT00304148 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 5,499 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 257-participant average among 14 other Renal Insufficiency, Chronic trials with a reported enrollment target (2040% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Renal Insufficiency, Chronic appearing as the primary indexed condition, and to 0 interventions.
NCT00304148 reports 12 study locations spanning 7 distinct geographic areas - top geographies include Ohio, California, Maryland.
Frequently Asked Questions
What is clinical trial NCT00304148 about?
NCT00304148 is a clinical study titled "SDCC - Prospective Cohort Study of Chronic Renal Insufficiency". Chronic kidney disease (CKD) is a silent epidemic affecting more than 37 million Americans. The burden of morbidity and mortality associated with CKD derives from its frequent progression to end-stage kidney disease (ESKD) and the disproportionate risk of cardiovascular disease (CVD) and associated ...
What is the current status of trial NCT00304148?
This trial is currently active not recruiting. The enrollment target is 5,499 participants. The study started on 2003-07. Estimated completion is 2028-06.
What conditions does trial NCT00304148 study?
This clinical trial studies the following conditions: Renal Insufficiency, Chronic.
Who is sponsoring clinical trial NCT00304148?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00304148 being conducted?
This trial has 12 study locations across California, Illinois, Louisiana, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Insufficiency, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neurovascular Transduction During Exercise in Chronic Kidney Disease
RECRUITING · Phase 2
-
Transformative Research in Diabetic Nephropathy 2.0
RECRUITING
-
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
RECRUITING · Phase 1
-
Penn Produce Prescription and Chronic Kidney Disease Study
ACTIVE NOT RECRUITING · NA
-
Acute Kidney Injury Genomics and Biomarkers in TAVR Study
ACTIVE NOT RECRUITING
-
Iron Dosing Pilot Study Using Model Predictive Control
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.